Intestinal surgery in advanced ovarian cancer.
OBJECTIVE
This review examines the current role of intestinal surgery in advanced ovarian cancer. Institutions differ considerably in surgical procedures and therapeutic outcomes for this disease. Moreover, therapeutic outcomes are influenced by the inclusion criteria for surgical procedures and the degree of surgical completion. We discuss the role of intestinal surgery and suggest surgical indications for intestinal surgery in advanced ovarian cancer.


RESULTS
Prognosis in advanced ovarian cancer is better when there is a smaller postoperative tumor mass. However, it is necessary to investigate the effects of intestinal surgery on residual tumor mass and its prognostic benefits. Here, recent reports were reviewed to ascertain the usefulness and safety of intestinal surgery for advanced ovarian cancer and examine surgical indications and institutional requirements.


CONCLUSIONS
By performing aggressive intestinal surgery such as combined bowel resection, optimal cytoreductive surgery can be performed in 70-98% of cases. The morbidity associated with intestinal surgery is acceptably low. Prognostic benefits for intestinal surgery are clear in patients with operable ovarian cancer with no residual disease. Women with suspected ovarian cancer should therefore be referred to centers with experienced tumor surgeons.
Takahashi
Osamu
O
Department of Obstetrics and Gynecology, Akita City Hospital, Kawamoto, Akita, Japan. ac060372@med.city.akita.akita.jp
Tanaka
Toshinobu
T
D003082:Colectomy; D018572:Disease-Free Survival; D005260:Female; D013509:Gynecologic Surgical Procedures; D006801:Humans; D009367:Neoplasm Staging; D018365:Neoplasm, Residual / Q000517:prevention & control / Q000601:surgery; D010051:Ovarian Neoplasms / Q000145:classification / Q000601:surgery*; D011379:Prognosis